| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Genedx Holdings Corp. (WGS) has 6 insiders with recent SEC Form 4 filings, including 0 buys and 15 sells. WGS is classified in the Life Sciences Tools & Services industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 3.01M | $166.66M | - | |
| Dir | 114.7K | $6.36M | - | |
| CEO | 93.8K | $5.20M | - | |
| CFO | 12.6K | $697.5K | - | |
| ? | 12.0K | $665.8K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 29, 2024 | Opko Health, Inc. | 10% Owner | Sell | 50,000 | $33.86 | $1,692,890.00 | -1.6% | +66.4% | +172.4% | |
| Jul 26, 2024 | Opko Health, Inc. | 10% Owner | Sell | 135,000 | $33.78 | $4,560,363.00 | -2.1% | +76.2% | +138.1% | |
| Jul 23, 2024 | Opko Health, Inc. | 10% Owner | Sell | 150,000 | $32.98 | $4,946,935.00 | -1.5% | +74.8% | +149.2% | |
| Jul 17, 2024 | Opko Health, Inc. | 10% Owner | Sell | 25,000 | $32.93 | $823,187.50 | -0.7% | +80.2% | +141.5% | |
| Jul 5, 2024 | Opko Health, Inc. | 10% Owner | Sell | 36,118 | $28.24 | $1,020,015.66 | -1.0% | +63.0% | +196.6% | |
| Jul 3, 2024 | Opko Health, Inc. | 10% Owner | Sell | 89,082 | $27.58 | $2,457,286.21 | -0.8% | +53.7% | +227.2% | |
| Jun 17, 2024 | Feeley Kevin47 | Chief Financial Officer | Sale+OE | 2,646 | $28.31 | $74,908.26 | -6.6% | +36.0% | +130.9% | |
| Jun 17, 2024 | Stueland Katherine | Chief Executive Officer | Sale+OE | 7,683 | $28.31 | $217,505.73 | -7.8% | +36.0% | +130.9% | |
| Jun 10, 2024 | Feeley Kevin47 | Chief Financial Officer | Sale+OE | 895 | $24.92 | $22,303.40 | -2.7% | +31.3% | +170.7% | |
| Jun 10, 2024 | Stueland Katherine | Chief Executive Officer | Sale+OE | 2,652 | $24.92 | $66,087.84 | -3.2% | +31.3% | +170.7% |